Malignant Solid Neoplasm Clinical Trials in Ann Arbor, Michigan
10 studies are recruiting for malignant solid neoplasm in Ann Arbor, Michigan right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Testing the Use of Neratinib or the Combination of Neratinib and Palbociclib Targeted Treatment for HER2+ Solid Tumors (A ComboMATCH Treatment Trial)
This phase II ComboMATCH treatment trial compares the effect of neratinib to the combination of neratinib and palbociclib in treating patients with HER2 positive solid tumors. Neratinib and palbociclib are in a class of medications called kinase inhibitors. They work by blocking the action of an ab…
- Stage
- Phase 2
- Ages
- 18 and older
- Site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
- Locations
- 194 in total
- Run by
- National Cancer Institute (NCI)
-
Collection of Research Data and Samples From Patients Treated With Immunotherapy to Study Its Side Effects
This study collects research data and samples from patients who experience immunotherapy side effects to store for use in future research studies. Studying research data and samples from patients who experience immunotherapy side effects may help researchers better understand how to predict, preven…
- Stage
- Not phased
- Ages
- Any age
- Site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
- Locations
- 625 in total
- Run by
- Alliance for Clinical Trials in Oncology
-
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
This study collects blood and tissue samples from patients with cancer and without cancer to evaluate tests for early cancer detection. Collecting and storing samples of blood and tissue from patients with and without cancer to study in the laboratory may help researchers develop tests for the earl…
- Stage
- Not phased
- Ages
- 40 to 75
- Site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
- Locations
- 745 in total
- Run by
- Alliance for Clinical Trials in Oncology
-
Triptorelin for the Prevention of Ovarian Damage in Adolescents and Young Adults With Cancer
This phase III trial compares the effect of giving triptorelin vs no triptorelin in preventing ovarian damage in adolescents and young adults (AYAs) with cancer receiving chemotherapy with alkylating agents. Alkylating agents are part of standard chemotherapy, but may cause damage to the ovaries. I…
- Stage
- Phase 3
- Ages
- Up to 39
- Site
- C S Mott Children's Hospital, Ann Arbor, Michigan
- Locations
- 206 in total
- Run by
- Children's Oncology Group
-
Project: Every Child for Younger Patients With Cancer
This study gathers health information for the Project: Every Child for younger patients with cancer. Gathering health information over time from younger patients with cancer may help doctors find better methods of treatment and on-going care.
- Stage
- Not phased
- Ages
- Up to 25
- Site
- C S Mott Children's Hospital, Ann Arbor, Michigan
- Locations
- 279 in total
- Run by
- Children's Oncology Group
-
Solution-Focused Brief Therapy for Support of Psychological Distress in Adolescent and Young Adult Cancer Survivors
This clinical trial evaluates the how well a virtually delivered solution-focused brief therapy (SFBT-C) works to decrease adolescent and young adult cancer survivors' psychological distress in comparison to enhanced treatment-as-usual care. Cancer and its treatment can have immediate and long-term…
- Stage
- Not phased
- Ages
- 15 to 39
- Site
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
- Run by
- University of Michigan Rogel Cancer Center
-
A Virtually Delivered Diet Intervention (LASO-3) for the Improvement of Chemotherapy-Induced Peripheral Neuropathy in Cancer Survivors Post-treatment
This clinical trial studies whether a virtually delivered diet intervention focused on lower added sugar, higher fiber, and higher omega 3 fatty acid (LASO-3) can be used to improve chemotherapy-induced peripheral neuropathy (CIPN) in cancer survivors after treatment. Cancer survivors often experie…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Michigan Rogel Cancer Center, Ann Arbor, Michigan
- Run by
- University of Michigan Rogel Cancer Center
-
Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors
This study examines how certain risk factors (such as age, gender, other medical conditions, and the type of immunotherapy used to treat the cancer) affect whether a patient with a malignant solid tumor will develop mild or serious side effects from the immunotherapy medications. Immunotherapy is t…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
- Locations
- 849 in total
- Run by
- SWOG Cancer Research Network
-
Collection and Storage of Tissue and Blood Samples From Patients With Cancer
This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs.
- Stage
- Not phased
- Ages
- 0 and older
- Site
- Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor, Michigan
- Locations
- 140 in total
- Run by
- National Cancer Institute LAO
-
A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
This clinical trial evaluates the usefulness of a self-monitoring platform for tracking medication safety events and concerns in patients with lung, colorectal, breast, and prostate cancer. Patients receiving oral anticancer agents often encounter challenges in managing complex treatment regimens, …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- University of Michigan Comprehensive Cancer Center, Ann Arbor, Michigan
- Run by
- University of Michigan Rogel Cancer Center
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.